Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Artelo Biosciences has expanded its existing research and worldwide commercial license agreement with The Research Foundation For The State University of New York, Stony Brook.
read more
Tuesday, January 09, 2024
Artelo Biosciences, Inc., a clinical-stage pharmaceutical company dedicated to modulating lipid-signaling pathways for developing treatments targeting cancer, pain, and neurological conditions, has chosen Worldwide Clinical Trials, a global contract ...
read more
Tuesday, October 29, 2019
Artelo Biosciences has selected Aptus Clinical as its CRO for the Company’s Phase 1b/2a randomized, placebo-controlled trial of ART27.13.
read more
Wednesday, March 15, 2023
Artisan Bio announced an extension of its research collaboration with Takeda which leverages Artisan's genome editing technology. The amended agreement builds on the companies' initial research program established in 2020 with a new research plan ...
read more
ARTMS and Telix have entered into a development collaboration agreement to employ ARTMS’ high activity production of Gallium-68 for Telix’s prostate cancer imaging product TLX591-CDx for imaging of prostate cancer with PET.
read more
Monday, February 10, 2020
Certara announced its discovery research relationship with Arvinas has expanded to include a greater diversity of small molecule drug discovery projects and data sources.
read more
Wednesday, November 15, 2017
Arvinas has expanded its ongoing license agreement with Genentech for the development of new therapeutics using Arvinas' novel PROTAC technology.
read more
Asahi Kasei Bioprocess America and GeminiBio entered into a strategic partnership to advance the application of inline buffer formulation (IBF) in the biopharmaceutical industry.
read more
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics. The partners will collaborate to build a cutting-edge oligonucleotide cGMP ...
read more
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics. The partners will collaborate to build a cutting-edge oligonucleotide cGMP ...
read more
Asahi Kasei has established Asahi Kasei Life Science, a new organizational structure dedicated to its bioprocess businesses. This move reflects the company’s commitment to addressing the evolving needs of the pharmaceutical industry by enhancing ...
read more
Monday, November 30, 2020
ProBioGen announced the closing of a master service agreement with Asahi Kasei Pharma.
read more
Wednesday, April 10, 2024
Ascend Advanced Therapies has acquired the CMC team and site in Alachua, Florida from Beacon Therapeutics. The transaction brings an operational good manufacturing practice (GMP) facility, process and analytical development capabilities, and ...
read more
Tuesday, September 24, 2024
Ascend Advanced Therapies (Ascend), a gene to GMP development partner, has confirmed multi-million-dollar investments supporting global infrastructure of the company. Expanded GMP suite capacity up to 500L scales and the addition of fill finish ...
read more
Ascend Advanced Therapies, a gene-to-GMP development service provider, has received GMP certification for Quality Control (QC) testing at its site in Munich, Germany.
read more